Will the ‘anti-woke’ movement derail DEI efforts in pharma?

The anti-DEI movement had been sweeping across America for years — and it was just a matter of time before it crashed into pharma.

For Kim Ribeiro, former head of diversity and patient inclusion at AbbVie, the shift became apparent following the U.S. Supreme Court’s decision to overturn affirmative action in higher education last year.